D. Ross Camidge, M.D., Ph.D., University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz Medical Campus

D. Ross Camidge, M.D., Ph.D., University of Colorado Cancer Center

Caption

D. Ross Camidge, M.D., Ph.D., and colleagues show that monitoring levels of blood tumor markers may predict when a lung cancer patient is progressing on targeted treatments.

Credit

University of Colorado Cancer Center

Usage Restrictions

with attribution

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.